Literature DB >> 6088377

A mutant strain of varicella-zoster virus deficient in thymidine kinase-inducing activity.

T Yokota, M Ogata, S Shigeta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6088377

Source DB:  PubMed          Journal:  Fukushima J Med Sci        ISSN： 0016-2590


× No keyword cloud information.
  4 in total

1.  In vitro activity of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine against newly isolated clinical varicella-zoster virus strains.

Authors:  M Baba; K Konno; S Shigeta; E De Clercq
Journal:  Eur J Clin Microbiol       Date:  1987-04       Impact factor: 3.267

2.  Inhibiting effect of (RS)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine on varicella-zoster virus replication in cell culture.

Authors:  G Abele; A Karlström; J Harmenberg; S Shigeta; A Larsson; B Lindborg; B Wahren
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

3.  Characterization of a varicella-zoster virus variant with altered thymidine kinase activity.

Authors:  S Shigeta; S Mori; T Yokota; K Konno; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191

4.  Inhibition of varicella-zoster virus-induced DNA polymerase by a new guanosine analog, 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine triphosphate.

Authors:  G Abele; B Eriksson; J Harmenberg; B Wahren
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.